Skip to main content
PegBio Co., Ltd. logo

PegBio Co., Ltd. — Investor Relations & Filings

Ticker · 2565 ISIN · CNE100006T44 HKEX Professional, scientific and technical activities
Open in API
Filings indexed 2,125 across all filing types
Latest filing 2017-03-06 Capital/Financing Update
Country HK Hong Kong
Listing HKEX 2565

About PegBio Co., Ltd.

http://www.pegbio.com

PegBio Co., Ltd. is a biotechnology company specializing in the in-house discovery and development of innovative therapies for chronic diseases, primarily focusing on the endocrine and metabolic fields. The company leverages its proprietary HECTORTM technology system to design and screen novel molecular entities, including peptide, protein, and small-molecule drugs, targeting unmet clinical needs. PegBio's robust pipeline addresses major chronic conditions such as Type 2 Diabetes (T2DM), obesity, and metabolic dysfunction-associated steatohepatitis (MASH). Key pipeline assets include long-acting GLP-1 receptor agonists, such as Vepinatide, developed for T2DM treatment and weight management. The company emphasizes creating complementary, multi-benefit product pipelines characterized by new targets, new sites, and new mechanisms of action.

Recent filings

Filing Released Lang Actions
DISCLOSEABLE TRANSACTION: DISPOSALS OF AVAILABLE-FOR-SALE INVESTMENTS
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the disposal of available-for-sale investments by the company. It details agreements for the sale of shares held by subsidiaries, the consideration, completion conditions, financial effects, and regulatory implications under the Listing Rules. The content focuses on transaction details and implications rather than presenting full financial statements or comprehensive financial performance data. The document is lengthy (15,000 characters) and contains detailed transaction information, which aligns with a Capital/Financing Update. It is not an Annual Report, Interim Report, or Earnings Release, nor is it a simple announcement of a report publication. It is not a regulatory filing or a management report. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2017-03-06 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 28 FEBRUARY 2017
Regulatory Filings Classification · 95% confidence The document is titled 'Monthly Return of Equity Issuer on Movements in Securities' for the month ended 28/02/2017, submitted to the Hong Kong Exchanges and Clearing Limited. It details movements in authorized and issued share capital, share options, warrants, convertibles, and other share-related activities. The content focuses on changes in share capital and securities movements rather than financial performance, earnings, or management commentary. It is a regulatory filing reporting share capital movements for a specific month, typical of a regulatory compliance report rather than a financial report or announcement. The document length is substantial (over 14,000 characters), and it contains detailed data rather than just an announcement or certification. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory compliance documents that do not fit other specific categories like capital changes (SHA) or share transactions (POS). It is not a capital/financing update (CAP) because it does not discuss fundraising or financing activities but rather reports on share capital movements as required by the exchange.
2017-03-01 English
EXTENSION OF LONG STOP DATE AND FURTHER DELAY IN DESPATCH OF CIRCULAR IN RELATION TO DISCLOSEABLE AND CONNECTED TRANSACTION
Regulatory Filings Classification · 95% confidence The document is an announcement from a company listed on the Hong Kong Stock Exchange regarding an extension of the long stop date and delay in the despatch of a circular related to a discloseable and connected transaction. It references previous announcements and details about the transaction and the expected timing of the circular. The document is relatively short (2751 characters) and primarily serves as an update on the timing of a circular rather than containing the circular itself or detailed financial data. This fits the profile of a Regulatory Filing (RNS) as it is a general regulatory announcement and does not contain the full report or financial statements. Therefore, the appropriate classification is Regulatory Filings (RNS).
2017-02-28 English
ANNOUNCEMENT PURSUANT TO RULE 3.7 OF THE TAKEOVERS CODE
M&A Activity Classification · 95% confidence The document is an announcement pursuant to Rule 3.7 of the Takeovers Code, referencing ongoing negotiations related to a possible transfer and subscription, with no formal agreements yet. It mentions the Takeovers Code multiple times and states that further announcements will be made as appropriate. The document is relatively short (3616 characters) and serves as an update on merger/takeover related activities without containing detailed financial data or full reports. This fits the category of M&A Activity announcements, which cover merger proposals or takeover bids and related updates.
2017-02-16 English
UPDATE ON THE NUMBER OF RELEVANT SECURITIES OF THE COMPANY PURSUANT TO RULE 3.8 OF THE TAKEOVERS CODE
M&A Activity Classification · 95% confidence The document is an announcement made pursuant to Rule 3.8 of the Takeovers Code, providing an update on the number of relevant securities of the company following the allotment and issue of new shares. It references previous announcements and the Takeovers Code, and includes reminders about disclosure obligations under the Takeovers Code. The document is relatively short (4609 characters) and is clearly an announcement rather than a full report or detailed financial statement. It does not contain financial statements, management discussion, or detailed financial data. It is related to takeover regulations and securities disclosures, which aligns with M&A activity but is more specifically an update on securities pursuant to takeover rules. Given the content and context, the most appropriate classification is M&A Activity (TAR), which covers announcements related to merger proposals or takeover bids and related securities updates under the Takeovers Code.
2017-02-15 English
NEXT DAY DISCLOSURE RETURN - CHANGE IN ISSUED SHARE CAPITAL
Transaction in Own Shares Classification · 95% confidence The document is a disclosure return related to changes in issued share capital and share buybacks for a Main Board listed issuer, Skyway Securities Group Limited. It includes detailed information on share issues, repurchases, and related notes referencing specific listing rules of the Hong Kong Stock Exchange. The content focuses on reporting share capital changes and repurchase activities rather than announcing a new report or providing financial results. This matches the description of a Transaction in Own Shares (POS) filing, which reports company buybacks or sales of its own shares. The document length and detail confirm it is the actual report, not just an announcement or certification.
2017-02-15 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.